DiaMedica Therapeutics (DMAC) Debt to Equity (2017)
DiaMedica Therapeutics filings provide 1 years of Debt to Equity readings, the most recent being $0.11 for Q4 2017.
- Quarterly Debt to Equity changed N/A to $0.11 in Q4 2017 from the year-ago period, while the trailing twelve-month figure was $0.11 through Dec 2017, changed N/A year-over-year, with the annual reading at $0.11 for FY2017, N/A changed from the prior year.
- Debt to Equity hit $0.11 in Q4 2017 for DiaMedica Therapeutics.
- Across five years, Debt to Equity topped out at $0.11 in Q4 2017 and bottomed at $0.11 in Q4 2017.